---
title: "Northeast Securities Reaffirms Their Buy Rating on Fujian Haixi Pharmaceuticals Co., Ltd. Class H (2637)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285826256.md"
description: "Northeast Securities has reaffirmed a Buy rating on Fujian Haixi Pharmaceuticals Co., Ltd. Class H (2637) as of May 8, setting a price target of HK$346.75. The stock closed at HK$236.00 last Friday. The analyst consensus for the company is Strong Buy, with a price target consensus of HK$320.72."
datetime: "2026-05-10T02:15:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285826256.md)
  - [en](https://longbridge.com/en/news/285826256.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285826256.md)
---

# Northeast Securities Reaffirms Their Buy Rating on Fujian Haixi Pharmaceuticals Co., Ltd. Class H (2637)

Northeast Securities analyst maintained a Buy rating on Fujian Haixi Pharmaceuticals Co., Ltd. Class H on May 8 and set a price target of HK$346.75. The company’s shares closed last Friday at HK$236.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Fujian Haixi Pharmaceuticals Co., Ltd. Class H has an analyst consensus of Strong Buy, with a price target consensus of HK$320.72.

### Related Stocks

- [02637.HK](https://longbridge.com/en/quote/02637.HK.md)
- [000686.CN](https://longbridge.com/en/quote/000686.CN.md)

## Related News & Research

- [Guohai Securities Sticks to Its Buy Rating for Fujian Haixi Pharmaceuticals Co., Ltd. Class H (2637)](https://longbridge.com/en/news/285489230.md)
- [Fujian Haixi Advances First-in-Class Oral Retinal Drug HXP056 Into Phase II](https://longbridge.com/en/news/280291010.md)
- [Trip.com executive attends Dalian inbound tourism promotion event with 400 international agents](https://longbridge.com/en/news/287071544.md)
- [Berenberg Bank Reaffirms Their Buy Rating on tonies SE Class A (TNIE)](https://longbridge.com/en/news/286369468.md)
- [JD.com, Inc. Class A (9618) Gets a Buy from China Merchants Securities](https://longbridge.com/en/news/286363442.md)